|
From
the Editor
..........................................................................................................................
Abdul Abyad,
MD, MPH, MBA, AGSF, AFCHSE (Chief Editor)
Address correspondence
to:
Abdul Abyad, MD, MPH, MBA, AGSF, AFCHSE (Editor)
Abyad Medical Center & Middle East Longevity
Institute
Azmi Street, Abdo Center, 2nd Floor
PO BOX 618, Tripoli LEBANON
Tel & Fax: 961 6 443684/5/6
Email: aabyad@cyberia.net.lb
Web: www.amc-lb.com
.........................................................................................................................
This is the eighth issue this year and the
current issue is rich with valuable papers from
the region. Dr Elghiblawi E reviewed a topic
of great importance in the middle east, that
is the process of writing a Scientific Paper
for publication. Dr Elghiblawi stressed
that writing up is a daunting task; it involves
a great deal of planning, preparation and time;
it is simply a skill born from practice. In
order to write, you need to read. The article
supplies the researcher with a few simple guidelines
on how to prepare, and write an organized scientific
paper, which ranges from its early drafting
in order to improve the manuscript, and then
its final publication.
A paper from Turkey attempted to assess
how many people have cancer patients (alive
or dead) in their homes. The authors administered
a questionnaire to 2035 people in 75 different
parts of the city. There were 100 (4.9%) people
who have been living with a patient diagnosed
as cancer and 333 people (16.4%) who had a history
of a patient dying from cancer in their home.
The authors concluded that cancer is a part
of our lives either with a patient in our house
or a relative who has died from cancer. Public
education and health services for home carers'
are needed for many people to care for these
cancer patients.
Dr Amro K did a randomized study to
compare the use of Azithromycin and co-Amoxiclav
in the treatment of symptoms and signs of acute
suppurative otitis media in children. He noted
satisfactory clinical response was measured
regarding symptoms and signs two weeks after
the beginning of therapy. They were 84.6% for
Azithromycin and 88% for Co-Amoxiclav. At day
28, 61 patients (82.4%) were cured on Azithromycin
compared with 66 patients (83.5 %) on Co-Amoxiclav.
The author concluded that Azithromycin given
for three days and Co-Amoxiclav for ten days
had similar efficacy; however, Azithromycin
was better tolerated.
A paper from Iran looked at the demographic
and clinical features in 131 Iranian patients
with cluster headache. The study was performed
in the Isfahan Medical University from June
2006 to June 2007. 131 patients with definite
cluster headache were selected randomly. The
authors concluded that on the basis of this
study, may be there is a regional and race difference
among different studies. According to treatability
of this type of headache, and morbidity and
costs that are produced by this disease, more
extensive studies on the base of prevalence,
predisposing factors, different aspects of treatment,
and prophylactic treatments should be taken
to provide patients with more suitable and effective
help.
A cross sectional survey was conducted in Iran
to evaluate knowledge and behavior related to
"self care" among women who attended
to Shiraz Health Center. A convenience sample
of 607 women were selected by cluster and random
sampling. 52.2% of women had good knowledge
about self care behavior. Knowledge of blood
cholesterol was highest rate among women (91.1%).
Good practice about screening tests was only
3.1% for control of blood pressure as routine,
was higher compared to other screening tests.
The authors concluded that practice of women
about screening tests especially as a routine,
is weak. With attention to the importance of
self care behavior in promotion of life quality
and life span, therefore nurses and health workers
must teach and encourage women about self care
behavior and attending screening tests.
Dr Muneizel S attempted to determine
the efficacy and side effects of tinidazole
compared with metronidazole in the treatment
of amoebiasis in Jordanian patients. A randomized
controlled clinical trial was carried out on
66 subjects with Entamoeba histolytica infestation.
Infected patients were treated with either tinidazole
or metronidazole (Tinidazole 2gm single dose
orally for 3 days and metronidazole 2gm single
dose orally for 3 days) . 27 of 32 patients
(87.5%) treated with tinidazole and 23 of 34
patients (67.5%) treated with metronidazole
had parasitological cure. Cure rates between
two groups were significant statistically (P<0.01).
The author concludes that Tinidazole was more
effective than metronidazole, produced fewer
and milder side effects, and is recommended
with high efficacy in treating intestinal amoebiasis.
A cohort study from Jordan looked to determine
effects of intrapartum risk factors for early
onset sepsis (EOS) on CRP levels in neonates
and to assess the suitability of this test in
diagnosing EOS. A total of 200 neonates were
studied. CRP levels in cord blood and neonatal
blood at 24 hours were estimated using commercial
kits. Elevated cord CRP levels was significantly
associated with rupture of membranes for 24
hours labour more than 12 hours and maternal
fever. Several intrapartum risk factors for
EOS can cause elevation in CRP levels. However,
this test may be useful in excluding infection.
|